Pricing Log in Create free account

Cel-Sci Corporation (CVM) vs NextCure, Inc. (NXTC)

Cel-Sci Corporation and NextCure, Inc. are both Biotechnology companies. Cel-Sci Corporation and NextCure, Inc. are of similar size ($31.5M and $30.6M). Across the 12 metrics below, Cel-Sci Corporation leads on 6 and NextCure, Inc. on 6.

Valuation

Metric CVM NXTC Biotechnology median
P/E n/m n/m 8.50
P/S 38.82 1.21 9.71
P/B 1.98 2.73 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 35.01 0.57 9.21
Earnings yield (63.81%) (139.42%) (33.15%)
Free cash flow yield (77.45%) (113.06%) (25.50%)

Profitability

Metric CVM NXTC Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (252.53%) (195.22%) (56.36%)
Return on assets (108.91%) (121.60%) (48.04%)
Return on invested capital (169.59%) 0.00% 0.00%

Growth

Metric CVM NXTC Biotechnology median
Revenue growth (TTM) 20.75% — 6.02%
EPS growth (last fiscal year) 59.06% 17.75% 30.26%
Revenue growth, 5-year CAGR 16.18% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CVM NXTC Biotechnology median
Debt to equity 0.35 0.00 0.00
Current ratio 1.48 3.47 4.72
Net debt to EBITDA 0.25 0.75 0.96

Dividend

Metric CVM NXTC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CVM NXTC Biotechnology median
Market cap 30.61m 31.49m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack